These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31388422)

  • 1. Efficacy and safety profile of doxofylline compared to theophylline in asthma: a meta-analysis.
    Rogliani P; Calzetta L; Ora J; Cazzola M; Matera MG
    Multidiscip Respir Med; 2019; 14():25. PubMed ID: 31388422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A long-term clinical trial on the efficacy and safety profile of doxofylline in Asthma: The LESDA study.
    Calzetta L; Matera MG; Goldstein MF; Fairweather WR; Howard WW; Cazzola M; Rogliani P
    Pulm Pharmacol Ther; 2020 Feb; 60():101883. PubMed ID: 31884206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of doxofylline compared to theophylline in asthma: A pooled analysis of functional and clinical outcomes from two multicentre, double-blind, randomized studies (DOROTHEO 1 and DOROTHEO 2).
    Calzetta L; Hanania NA; Dini FL; Goldstein MF; Fairweather WR; Howard WW; Cazzola M
    Pulm Pharmacol Ther; 2018 Dec; 53():20-26. PubMed ID: 30219705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of doxofylline compared to theophylline in chronic reversible asthma -- a double-blind randomized placebo-controlled multicentre clinical trial.
    Goldstein MF; Chervinsky P
    Med Sci Monit; 2002 Apr; 8(4):CR297-304. PubMed ID: 11951074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of doxofylline in COPD: A pairwise meta-analysis.
    Cazzola M; Calzetta L; Rogliani P; Page C; Matera MG
    Pulm Pharmacol Ther; 2018 Aug; 51():1-9. PubMed ID: 29705620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety profile of doxofylline in asthma: a meta-analysis.
    Gao F; Li J; Hou Y; Sun S; Chen Y; Cao F; Xu H; Li J
    J Asthma; 2024 Sep; ():1-11. PubMed ID: 39264111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doxofylline: a promising methylxanthine derivative for the treatment of asthma and chronic obstructive pulmonary disease.
    Shukla D; Chakraborty S; Singh S; Mishra B
    Expert Opin Pharmacother; 2009 Oct; 10(14):2343-56. PubMed ID: 19678793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. To study the efficacy and safety of doxophylline and theophylline in bronchial asthma.
    Margay SM; Farhat S; Kaur S; Teli HA
    J Clin Diagn Res; 2015 Apr; 9(4):FC05-8. PubMed ID: 26023566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of the efficacy and safety of theophylline and doxofylline in patients with bronchial asthma and chronic obstructive pulmonary disease.
    Lal D; Manocha S; Ray A; Vijayan VK; Kumar R
    J Basic Clin Physiol Pharmacol; 2015 Sep; 26(5):443-51. PubMed ID: 25894641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of doxofylline in asthma and COPD.
    Cazzola M; Matera MG
    Respir Med; 2020 Apr; 164():105904. PubMed ID: 32094104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of montelukast, doxofylline, and tiotropium with budesonide for the treatment of asthma: which is the best among the second-line treatment? A randomized trial.
    Rajanandh MG; Nageswari AD; Ilango K
    Clin Ther; 2015 Feb; 37(2):418-26. PubMed ID: 25577543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety profile of xanthines in COPD: a network meta-analysis.
    Cazzola M; Calzetta L; Barnes PJ; Criner GJ; Martinez FJ; Papi A; Gabriella Matera M
    Eur Respir Rev; 2018 Jun; 27(148):. PubMed ID: 29720510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Meta-analysis of efficacy and safety of oral theophylline in chronic obstructive pulmonary disease].
    Wang CH; Zhang Q; Li M; Fu PF; Yan ZM; Peng AM; Zhang GL
    Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(8):540-6. PubMed ID: 20367966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylxanthine drug therapy in chronic heart failure associated with hypoxaemia: double-blind placebo-controlled clinical trial of doxofylline versus theophylline and bamifylline.
    Dini FL; Pasini G; Cortellini G; Cani E; Bettini R; Garagnani A; Gobbi G; Greco A; Onorato G; Pasini P
    Int J Clin Pharmacol Res; 1993; 13(6):305-16. PubMed ID: 8088931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of moderate chronic obstructive pulmonary disease (stable) with doxofylline compared with slow release theophylline--a multicentre trial.
    Santra CK
    J Indian Med Assoc; 2008 Dec; 106(12):791-2, 794. PubMed ID: 19370950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of reversible chronic airways obstruction with doxofylline compared with slow-release theophylline: a double-blind, randomized, multicentre trial.
    Melillo G; Balzano G; Jodice F; De Felice A; Campisi V; Capone M; Di Filippo A; Foddai G; Franzone JS; Grossi E
    Int J Clin Pharmacol Res; 1989; 9(6):397-405. PubMed ID: 2699466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary function assessment in mild to moderate persistent asthma patients receiving montelukast, doxofylline, and tiotropium with budesonide: a randomized controlled study.
    Rajanandh MG; Nageswari AD; Ilango K
    Clin Ther; 2014 Apr; 36(4):526-33. PubMed ID: 24650447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxofylline does not increase formoterol-induced cAMP nor MKP-1 expression in ASM cells resulting in lack of anti-inflammatory effect.
    Patel BS; Kugel MJ; Baehring G; Ammit AJ
    Pulm Pharmacol Ther; 2017 Aug; 45():34-39. PubMed ID: 28414142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of anti-inflammatory mechanisms between doxofylline and theophylline in human monocytes.
    Talmon M; Massara E; Brunini C; Fresu LG
    Pulm Pharmacol Ther; 2019 Dec; 59():101851. PubMed ID: 31563516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxofylline is not just another theophylline!
    Matera MG; Page C; Cazzola M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3487-3493. PubMed ID: 29255355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.